Researchers examine papillary anatomic and circumpapillary microperimetric assessments in glaucoma testing for patients with high myopia.
A study shows how access to parks and fields can limit screen time and impact visual health.
In a large trial, overminus therapy enhanced intermittent exotropia control but deepened the risk of myopic change, including >1.0 D.
After dilation, phentolamine mesylate ophthalmic solution returned pupil diameter to baseline approximately 2 hours sooner than placebo.
A report reviews the feasibility of managing ectasia that develops after a refractive procedure using a combination of 2 techniques.
Researchers utilized 7020 fundus images to teach machines to recognize the condition.
Investigators review treatment methods across 2 groups of young patients.
Researchers reviewed compliance among patients in the See Well to Learn program.
A group with no or limited stereovision performed similarly to controls in 2D and 3D depth perception tasks.
A study shows the effects of these devices are no different than standard clear lenses.
Investigation shows differences in vessel density changes in the deep capillary plexus between glaucomatous eyes with high myopia those without.
Age, sex impact changes to pupil size following cataract extraction.
Patients can likely be managed using the same techniques.
Study offers option for those with residual refractive error after primary PRK.
Researchers show the application of preoperative meibography.
Study compares unilateral medial rectus recession and bilateral medial rectus recession.
Current single corneal topography or tomography devices can produce false-negative results, possibly keeping patients from being cleared for surgery.
Researchers used study data to investigate the effect of atropine drops for myopia control on patients of various ages.
The refractive procedure is effective, safe, and predictable for myopic astigmatism of more than 2.00 D.
The study did not meet its primary endpoint of a 0.3 logMAR difference between treated and untreated eyes at week 48 , but it did demonstrate bilateral improvement of visual acuity from nadir to week 96.